MedCap AB/Skr MCAP
08:00
10:05
12:15
14:20
16:25
1D1W1MYTD1Y5YMAX
About MedCap AB
MedCap AB, established in 2001 and headquartered in Stockholm, Sweden, is a private equity firm specializing in the acquisition and development of small to medium-sized companies within the life sciences sector. The firm focuses on three primary business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap's portfolio includes subsidiaries such as Abilia, which operates in assistive technology; Cardiolex, specializing in ECG solutions; and Unimedic, involved in specialty pharmaceuticals. The company primarily targets investments in Northern Europe, aiming to support businesses with international growth potential. MedCap typically acquires majority stakes, providing capital, expertise, and networks to foster long-term development.
Ticker
Skr MCAP
Sector
Primary listing
XSTO
Employees
592
Headquarters
Stockholm, Sweden
Website
MedCap AB Metrics
BasicAdvanced
kr 7.7B
38.76
kr 13.13
0.37
-
Price and volume
Market cap
kr 7.7B
Beta
0.37
52-week high
kr 677.00
52-week low
kr 329.00
Average daily volume
12K
Financial strength
Current ratio
2.338
Quick ratio
1.633
Long term debt to equity
30.413
Total debt to equity
35.996
Interest coverage (TTM)
13.04%
Profitability
EBITDA (TTM)
336
Gross margin (TTM)
58.08%
Net profit margin (TTM)
9.89%
Operating margin (TTM)
12.83%
Effective tax rate (TTM)
22.79%
Revenue per employee (TTM)
kr 3,360,000
Management effectiveness
Return on assets (TTM)
7.30%
Return on equity (TTM)
15.25%
Valuation
Price to earnings (TTM)
38.765
Price to revenue (TTM)
3.82
Price to book
5.47
Price to tangible book (TTM)
23.82
Price to free cash flow (TTM)
29.435
Free cash flow yield (TTM)
3.40%
Free cash flow per share (TTM)
17.292
Growth
Revenue change (TTM)
11.22%
Earnings per share change (TTM)
-14.16%
3-year revenue growth (CAGR)
23.54%
3-year earnings per share growth (CAGR)
18.46%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MedCap AB stock?
MedCap AB (MCAP) has a market cap of Skr7.7B as of January 29, 2026.
What is the P/E ratio for MedCap AB stock?
The price to earnings (P/E) ratio for MedCap AB (MCAP) stock is 38.76 as of January 29, 2026.
Does MedCap AB stock pay dividends?
No, MedCap AB (MCAP) stock does not pay dividends to its shareholders as of January 29, 2026.
When is the next MedCap AB dividend payment date?
MedCap AB (MCAP) stock does not pay dividends to its shareholders.
What is the beta indicator for MedCap AB?
MedCap AB (MCAP) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.